Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance...

No prior work had resolved the challenges of achieving quantitative reliability for diffusion-weighted imaging on low-field magnetic resonance linear accelerators. That uncertainty drove concerns regarding the utility of these systems for monitoring tumor cellularity. Prior research has shown that standard echo planar imaging protocols often suffer from significant geometric distortions in these environments. This gap motivated the development of specialized acquisition sequences to improve diagnostic performance. It was already known that high-field scanners provide superior signal, yet they lack the integration required for real-time radiotherapy guidance. That limitation hindered the ability to track cellular proliferation during daily treatment fractions. This study addresses the need for validated imaging protocols that maintain geometric fidelity across the field of view. Researchers sought to confirm whether low-field systems could match the quantitative standards of diagnostic equipment.

The primary aim of this study is to validate the accuracy, repeatability, and geometric precision of apparent diffusion coefficient maps on a 0.35 T magnetic resonance linear accelerator. Researchers sought to address the lack of quantitative reliability in previous attempts to integrate diffusion-weighted imaging into radiotherapy workflows. This gap motivated the development of an echo planar imaging protocol specifically tailored for low-field environments. The team investigated whether this approach could provide consistent data for monitoring tumor cellularity during treatment. That uncertainty drove the need for a rigorous comparison between the low-field system and standard diagnostic scanners. No prior work had resolved the technical challenges of maintaining spatial fidelity while performing functional imaging on these integrated devices. The authors intended to demonstrate the potential for longitudinal patient imaging in a clinical setting. This work provides a foundation for incorporating advanced imaging metrics into daily radiotherapy guidance for sarcoma patients.

Review Approach involved evaluating a specialized echo planar imaging protocol designed for a 0.35 T magnetic resonance linear accelerator. The team assessed quantitative accuracy by comparing phantom measurements against established reference values across three distinct timepoints. To quantify geometric precision, investigators measured the distance between 93 phantom features on both the low-field system and a 3.0 T diagnostic scanner. These results were validated against spatially precise computed tomography images to determine system-dependent distortions. The researchers also performed an in vivo analysis by acquiring same-day maps from five sarcoma patients undergoing radiotherapy. This approach allowed for the comparison of performance metrics between the two imaging platforms. Multiple timepoints were utilized for patient scans to test the repeatability of the proposed sequence. The entire methodology focused on ensuring that the imaging workflow remained compatible with standard clinical radiotherapy procedures.

Key Findings From the Literature indicate that the echo planar imaging protocol produces accurate apparent diffusion coefficient maps on the 0.35 T system. Significant discrepancies in quantification were observed only at high diffusion values during phantom testing. Average geometric distortions in the central slice measured 0.35 mm for the linear accelerator and 0.85 mm for the diagnostic scanner. At 5.4 cm off-center, the linear accelerator demonstrated a distortion of 0.66 mm compared to 2.14 mm for the diagnostic system. Sarcoma patients exhibited a mean pretreatment apparent diffusion coefficient of 910x10^-6 mm^2/s when imaged on the linear accelerator. The data confirm that the acquisition of repeatable and precise maps is achievable within the low-field environment. These results demonstrate that the linear accelerator system maintains superior geometric fidelity in peripheral regions relative to diagnostic hardware. The findings establish a baseline for utilizing this functional imaging technique in longitudinal patient monitoring.

Synthesis and Implications reveal that the proposed echo planar imaging approach enables reliable quantitative mapping on low-field systems. The authors suggest that this methodology provides a viable pathway for longitudinal monitoring of tumor response during radiotherapy. Findings indicate that geometric fidelity on the linear accelerator system exceeds that of standard diagnostic scanners in off-center regions. The researchers propose that the observed discrepancies at high diffusion values remain manageable for clinical applications. Data synthesis confirms that same-day patient imaging is feasible for tracking changes in cellularity over time. The authors conclude that their protocol successfully mitigates common distortions associated with low-field magnetic resonance environments. This work supports the integration of advanced functional imaging into daily treatment workflows for sarcoma patients. The evidence suggests that low-field systems can serve as robust tools for quantitative assessment in the radiotherapy clinic.